According to a new report published by Allied Market Research, titled, " — Antibacterial Coatings Market for Medical Implants: Global Opportunity Analysis and Industry Forecast, 2017-2023," the market was valued at $120.22 million in 2016, and is projected to reach $343.16 million by 2023, registering a CAGR of 16.1% from 2017 to 2023. Metallic coatings segment held around three-fourths share of the total market in 2016.
Antibacterial coatings are materials that prevent the bacterial adhesion and biofilm formation on the surface of medical implants. In addition, they act as anti-thrombotic coating, which prevents the formation of thrombus during bacterial infections after the surgery in patient. So accordingly, medical implants are coated with antibacterial coating to obtain an ideal potent surface that can provide protection against the pathogens.
Click Here To Access Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/4462
The major factors that drive the global antibacterial coatings market for medical implants are increase in incidence of implant-associated infections, demand for implantable devices, rise in bone related and cardiovascular disorders, and growth of geriatric population. However, high cost of antibacterial coatings, few drawbacks of silver coatings, and time-consuming regulatory approvals are expected to restrain the market growth. Conversely, growth in need of better healthcare services in the emerging markets, such as China and India, and development of novel antibacterial coatings are expected to provide lucrative opportunities to the market players.
The metallic coatings segment occupied the highest share in 2016, owing to the usage applicability and availability of metallic coatings in medical & clinical settings. Furthermore, the metallic coating segment is expected continue its dominance in the market during the forecast period. The utilization rate of antibacterial coating for cardiac implants is high, however orthopedic implants is expected to grow at a high CAGR during the forecast period. This is attributed to increase in incidence of bone related disorders such as fractures or replacement of joints leading rise in use of orthopedic implants.
For Purchase Enquiry: @ https://www.alliedmarketresearch.com/purchase-enquiry/4462
Key Findings of the Antibacterial Coatings Market:
• Non-metallic coating segment is expected to grow at a CAGR of 13.8% from 2017 to 2023.
• Metallic coatings segment accounted for around three-fourths share of the global antibacterial coatings market for medical implants in 2016.
• Cardiac implants segment accounted for more than one-fifth share of the global antibacterial coatings market for medical implants in 2016.
• Asia-Pacific is expected to grow at the highest CAGR of 17.4%, from 2017 to 2023.
• North America accounted for around one-third share of the global antibacterial coatings market for medical implants in 2016.
North America was the leading revenue contributor to the global antibacterial coatings market for medical implants. This is attributed to the early adoption of technologically advanced coating and high use of implantable devices due to rise in incidence of chronic disorders. However, Asia-Pacific is expected to grow at the highest CAGR during the study period, due to increase in affordability, surge in healthcare expenditure, and growth in awareness about implantation surgeries.
The major companies profiled in the report are aap Implantate AG, AST Products, Inc., BioCote Ltd, Covalon Technologies Ltd., DOT GmbH, Harland Medical Systems Inc., Hydromer, Inc., Koninklijke DSM N.V., Sciessent LLC, and Specialty Coating Systems, Inc.
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Release ID: 89035835